Codexis CDXS
NASDAQ CDXS
$1.67 +0.09 (+5.70%)
At close: Aug 21, 2026 · 4:00 PM EDT

Codexis (CDXS) Amortization of Deferred Charges (2020 - 2026)

Codexis (CDXS) posted quarterly Amortization of Deferred Charges of $935000.0 for Q1 2026, up 232.74% year-over-year from $281000.0 in Q1 2025, and up 207.1% quarter-over-quarter from -$873000.0 in Q4 2025.

Codexis (CDXS) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends

Codexis' Amortization of Deferred Charges history runs 7 years deep, the most recent figure standing at $935000.0 for Q1 2026.

  • In Q1 2026, Amortization of Deferred Charges rose 232.74% year-over-year to $935000.0; the TTM figure through Mar 2026 stood at $2.0 million (up 80.72% YoY), while the FY2025 annual figure was $1.3 million, up 47.46% from the prior year.
  • Amortization of Deferred Charges for Q1 2026 stood at $935000.0, up from -$873000.0 in the prior quarter.
  • The five-year high for Amortization of Deferred Charges was $3.6 million in Q3 2023, with the low at -$3.6 million in Q4 2023.
  • The 5-year median for Amortization of Deferred Charges is $291000.0 (2025), against an average of $183823.5.
  • The sharpest annual moves came in 2022 and 2025: Amortization of Deferred Charges tumbled 523.65% in 2022, then jumped 242.68% in 2025.
  • Codexis' Amortization of Deferred Charges stood at -$3.6 million in 2022, then declined by 0.8% to -$3.6 million in 2023, then jumped by 59.45% to -$1.5 million in 2024, then surged by 40.97% to -$873000.0 in 2025, then surged by 207.1% to $935000.0 in 2026.
  • Business Quant data shows CDXS's Amortization of Deferred Charges at $935000.0 in Q1 2026, -$873000.0 in Q4 2025, and $1.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Codexis 152.06 Mn 97.14 Mn 11.40 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 947,000.00
Jun 30, 2026 947,000.00
Mar 31, 2026 935,000.00
Mar 31, 2026 935,000.00
Dec 31, 2025 -873,000.00
Dec 31, 2025 -873,000.00
Sep 30, 2025 1.61 Mn
Sep 30, 2025 1.61 Mn
Jun 30, 2025 291,000.00
Jun 30, 2025 291,000.00
Mar 31, 2025 281,000.00
Mar 31, 2025 281,000.00
Dec 31, 2024 -1.48 Mn
Dec 31, 2024 -1.48 Mn
Sep 30, 2024 2.02 Mn
Sep 30, 2024 2.02 Mn
Jun 30, 2024 263,000.00
Jun 30, 2024 263,000.00
Mar 31, 2024 82,000.00
Mar 31, 2024 82,000.00